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S U M M A R Y
Neisseria meningitidis remains the leading cause of bacterial meningitis and septicemia worldwide. We
describe a case of invasive meningococcal infection caused by serogroup X N. meningitidis with a unique
sequence type (ST-7) in China. The strain may have arisen from locally prevalent hypervirulent
serogroup A clones by capsular switching events.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Neisseria meningitidis remains the leading cause of bacterial
meningitis and septicemia worldwide. Based on the different
capsular polysaccharide structures, 13 different serogroups of N.
meningitidis have been identiﬁed, and the majority of cases are
caused by six of these serogroups (A, B, C, W, X, and Y).1 In China,
the morbidity rate of meningococcal disease has declined sharply
since the introduction of a national immunization campaign
starting in the 1980s with a serogroup A polysaccharide-based
vaccine. Since the year 2000, the rate has been maintained at below
0.2 per 100 000 population. Serogroups C and B N. meningitidis
have been the prevalent strains isolated in recent years, whereas
only one case of invasive infection with meningococcal serogroup
X (MenX) has been reported in China.2 We report a case of invasive
meningococcal disease caused by a serogroup X strain with a
unique sequence type (ST-7) in Zhejiang Province, China.* Corresponding author. Tel./fax: +86 571 87115171.
E-mail address: shyxie@cdc.zj.cn (S. Xie).
http://dx.doi.org/10.1016/j.ijid.2014.07.022
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).2. Case report
The case was a 19-year-old female who experienced sudden
high fever, chills, and faintness on the morning of May 13,
2013. These symptoms were followed by the onset of hemorrhagic
rashes and petechiae at around 5:00 p.m. on the same day. Later
that day she presented to a local hospital; blood tests taken at that
time revealed a leukocyte count of 13.39  109/l, with a 92%
proportion of neutrophils. She was immediately transferred and
admitted to a municipal hospital without any treatment. During
the admission process, the patient vomited once, complained of a
headache, and more petechiae were observed. A physical
examination revealed her body temperature to be 38.5 8C, and a
blood pressure reading was 60/40 mmHg. She also presented the
symptom of a stiff neck, and Kernig’s sign was elicited.
A blood culture from the sample that was drawn on May
13 during the admission was found to be N. meningitidis-positive.
The isolated bacterial strain was submitted to the Laboratory of
Zhejiang Provincial Center for Disease Control and Prevention and
it was subsequently identiﬁed as serogroup X N. meningitidis by
slide agglutination test with a speciﬁc antiserum (Remel, Dartford,
Kent, UK). In addition, it was further conﬁrmed positive for
serogroup X by serogroup-speciﬁc real-time PCR assays. Culture of
cerebrospinal ﬂuid (CSF) obtained on May 17, after antibiotics had
been administered, was negative.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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bioMe´rieux, Solna, Stockholm, Sweden). The minimum inhibitory
concentrations (MICs) for ampicillin, azithromycin, ceftriaxone,
chloramphenicol, ciproﬂoxacin, levoﬂoxacin, meropenem, mino-
cycline, penicillin, and rifampin were 1.0 mg/ml, 1.5 mg/ml,
<0.016 mg/ml, 0.75 mg/ml, 0.19 mg/ml, 0.19 mg/ml, 0.032 mg/ml,
0.75 mg/ml, 0.125 mg/ml, and 0.047 mg/ml, respectively. Thus theFigure 1. The eBURST population structure of Neisseria meningitidis isolates from the Pub
type (ST) numbers): (A) serogroup X; (B) serogroup A. Each circle represents a single ST
represent STs found only in carriers, green numbers represent STs found only in invas
represent single-locus variants.isolate was sensitive to most of the antibiotics, except penicillin
and ciproﬂoxacin. This isolate was moderately sensitive to
penicillin and ciproﬂoxacin.
The patient received pressor therapy (dopamine and norepi-
nephrine injection) at admission, followed by anti-infection and
supportive treatments. She recovered fully and was discharged
19 days later without observable sequelae. The patient was aMLST database (825 isolates obtained since the year 2000 with assigned sequence
, with the area proportional to the number of isolates of that type. Black numbers
ive cases, and blue numbers represent STs found in both of them. The black lines
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not report other identiﬁable risk factors before the occurrence of
the disease, such as an epidemiological contact history. Anti-HIV
antibody testing was negative and the immunization history of the
patient with regard to the meningococcal vaccine was unknown.
The isolate was assayed by multilocus sequence typing (MLST)
method as per the protocols speciﬁed on the Neisseria MLST
website (http://pubmlst.org/neisseria/). Alleles, sequence type
(ST), and clonal complex were queried and assigned by comparison
to the PubMLST database on the website. The ST of this isolate was
identiﬁed as ST-7 (a member of the subgroup III/ST-5 clonal
complex). It is the ﬁrst strain of ST-7 serogroup X in the database so
far.
In order to explore the correlations between the different
strains of MenX, eBURST v. 3.0 (http://eburst.mlst.net/) was used to
display the population snapshot of the strains from the PubMLST
database. ST-7 was demonstrated as a singleton; in fact it was
found to share no more than two common alleles with any other
serogroup X strain (a total seven alleles were analyzed).
3. Discussion
In the past, serogroup X N. meningitidis has been considered a
rare cause of invasive cases, but in the last decade, the number of
outbreaks has increased in the African meningitis belt. In China,
only a few serogroup X strains have been isolated from carriers so
far, and the case reported here is only the second case in our
country to date. The ﬁrst reported case caused by serogroup X N.
meningitidis in China was a 14-year-old boy in Beijing and the ST
number was newly assigned as ST-5944 in January 2007.2
In the PubMLST database, serogroup X strains comprise only a
minor proportion of the whole N. meningitidis isolates (1%, 267/
25 667, as on October 18, 2013), but they exhibit genetic
complexity. On October 18, 2013, with the most stringent group
deﬁnition, 84 of 259 strains (32%) that had been assayed and had
an assigned ST number were singletons. They cannot be classiﬁed
into any eBURST group (i.e., they differ at three or more loci from
every other strain in the dataset). The ST-7 strain we report here is
the only one of the serogroup X strain and the eBURST analysis did
not show close correlations with any other serogroup X strains(Figure 1). According to the deﬁnition of ‘capsular switching’ in a
meningococcal isolate, it is expected to occur when the ST of a
serogroup is not generally associated with the clonal complex
observed;3 thus we hypothesize that the ST-7 serogroup X strain
we isolated may have arisen from locally prevalent hypervirulent
serogroup A clones. A study by Zhou et al.4 reported that the ST-7
clone emerged in China in the late 1980s, and it replaced the ST-5
clone as the dominant lineage circulating in China from
2000. Capsular switching could explain the recent appearance of
the ST-7 serogroup C strains in China as well.
Capsular switching is deemed the result of horizontal genetic
exchange by transformation and recombination in the locus of
serogroup-speciﬁc capsule biosynthesis genes.5 It is a mechanism
of escape from protective immunity induced by vaccine or natural
infection. This phenomenon has attracted a certain amount of
attention already, as it will reduce the effectiveness of capsule-
based vaccination programs. Further epidemiological and micro-
biological surveillance is needed to monitor the changing trend in
serogroup proﬁle of meningococcal diseases.
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